Skip to content
Sulfacetamide
Blephamide, Cetapred, Fml-s, Gyne-sulf, Klaron, Metimyd, Predamide, Predsulfair, Sulphrin, Sulster, Sultrin, Trysul, Vagilia, Vasocidin (sulfacetamide) is a small molecule pharmaceutical. Sulfacetamide was first approved as Blephamide on 1982-01-01. It is used to treat bacterial infections, bacterial skin diseases, corneal ulcer, ear diseases, and seborrheic dermatitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
otorhinolaryngologic diseasesD010038
eye diseasesD005128
skin and connective tissue diseasesD017437
Trade Name
FDA
EMA
Klaron (generic drugs available since 1982-01-01, discontinued: Bleph, Cetamide, Isopto cetamide, Ocusulf, Sulamyd, Sulf, Sulfacel, Sulfair, Sulten)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Fluorometholone
+
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
FML-SAllerganN-019525 DISCN1989-09-29
1 products
Hide discontinued
Prednisolone acetate
+
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
BLEPHAMIDEAllerganN-012813 DISCN1982-01-01
1 products, RLD
METIMYDMerck Sharp & DohmeN-010210 DISCN1982-01-01
2 products
Hide discontinued
Prednisolone sodium phosphate
+
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
VASOCIDINNovartisN-018988 DISCN1988-08-26
1 products, RLD
Hide discontinued
Sulfacetamide sodium
Tradename
Company
Number
Date
Products
KLARONBausch Health CompaniesN-019931 RX1996-12-23
1 products, RLD, RS
Show 1 discontinued
Sulfacetamide
+
Sulfathiazole)
+
Triple sulfa (sulfabenzamide
Tradename
Company
Number
Date
Products
SULTRINJohnson & JohnsonN-005794 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
blephamideNew Drug Application2013-11-15
cetamide isopto cetamide2006-11-20
fml-s2007-02-20
klaronNew Drug Application2020-08-31
sulfacetamide sodiumANDA2023-06-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
bacterial skin diseases—D017192—
corneal ulcer—D003320H16.0
ear diseasesEFO_1001455D004427H93.9
seborrheic dermatitis—D012628L21
trachoma—D014141A71
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D10: Anti-acne preparations
— D10A: Anti-acne preparations for topical use
— D10AF: Antiinfectives for treatment of acne
— D10AF06: Sulfacetamide
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AB: Sulfonamides, ophthalmologic antiinfectives
— S01AB04: Sulfacetamide
HCPCS
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hypertrophic cardiomyopathyD002312EFO_0000538I42.112———3
Dilated cardiomyopathyD002311EFO_0000407I42.021———2
Heart failureD006333EFO_0003144I5011———1
Ventricular outflow obstructionD014694EFO_1001448—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—5————5
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSULFACETAMIDE
INNsulfacetamide
Description
Sulfacetamide is a sulfonamide that is sulfanilamide acylated on the sulfonamide nitrogen. It has a role as an antimicrobial agent, an antiinfective agent, an EC 2.5.1.15 (dihydropteroate synthase) inhibitor and an antibacterial drug. It is a substituted aniline and a N-sulfonylcarboxamide. It is functionally related to a sulfanilamide. It is a conjugate acid of a sulfacetamide(1-).
Classification
Small molecule
Drug classantimicrobials (sulfonamides derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(=O)NS(=O)(=O)c1ccc(N)cc1
Identifiers
PDB—
CAS-ID144-80-9
RxCUI10169
ChEMBL IDCHEMBL455
ChEBI ID63845
PubChem CID5320
DrugBankDB00634
UNII ID4965G3J0F5 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 895 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
14 adverse events reported
View more details